Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants.
Signal Transduct Target Ther
; 7(1): 42, 2022 02 08.
Article
en En
| MEDLINE
| ID: mdl-35136040
ABSTRACT
SARS-CoV-2 variants have evolved a variety of critical mutations, leading to antigenicity changes and immune escape. The recent emerging SARS-CoV-2 Omicron variant attracted global attention due to its significant resistance to current antibody therapies and vaccines. Here, we profiled the mutations of Omicron and other various circulating SARS-CoV-2 variants in parallel by computational interface analysis and in vitro experimental assays. We identified critical mutations that lead to antigenicity changes and diminished neutralization efficiency of a panel of 14 antibodies due to diverse molecular mechanisms influencing the antigen-antibody interaction. Our study identified that Omicron exhibited extraordinary potency in immune escape compared to the other variants of concern, and explores the application of computational interface analysis in SARS-CoV-2 mutation surveillance and demonstrates its potential for the early identification of concerning variants, providing preliminary guidance for neutralizing antibody therapy.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Anticuerpos Neutralizantes
/
Evasión Inmune
/
SARS-CoV-2
/
COVID-19
/
Anticuerpos Antivirales
/
Antígenos Virales
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Signal Transduct Target Ther
Año:
2022
Tipo del documento:
Article